GET STARTED

Want Answers Fast? Text Us at (954)-738-2512

  1. Home
    2.  | 
  2. Muscle Growth
    3.  | Tesamorelin

Tesamorelin

Tesamorelin is a growth hormone-releasing hormone (GHRH) analog made up of 44 amino acids that has been shown to increase growth hormone and IGF-1 levels. Tesamorelin is currently the most effective GH releasing hormone on the market. It binds and stimulates human GHRH receptors with similar potency as our own natural GHRH. It is combined with a GHRP for optimal results.

Applications

  • Influences bone mineral density
  • Supports muscle metabolism
  • Helps lipid metabolism
  • Controls inflammation
  • Enhances vascular health
  • Contributes to improved cardiovascular mortality
  • Reduction of excess abdominal fat

Dosing

    1mg 1-2 times per day, 5 days a week.

    Pricing

    Contact for pricing.

    Ready to optimize your health?

    GET STARTED

    Tesamorelin Clinical Information

    Mechanism

    Tesamorelin is a GHRH analog FDA-approved for reduction of visceral adipose tissue in HIV-associated lipodystrophy. Off-label, it is used for visceral fat reduction and metabolic support.

    Common Uses

    • Visceral (intra-abdominal) fat reduction
    • Metabolic and lipid profile support
    • Anti-aging and body composition adjunct

    Dosing

    Typical clinical dose is 1–2 mg subcutaneously daily. Cycle 3–6 months with reassessment.

    Side Effects

    • Injection-site reactions
    • Joint stiffness or pain
    • Mild fluid retention
    • Elevated IGF-1 (monitor)

    Contraindications

    • Active malignancy
    • Pregnancy or breastfeeding
    • Pituitary disease (case-by-case)
    • Known hypersensitivity



    Medically reviewed by: Diana Medina, MMS, PA-C — Florida-licensed Physician Assistant

    Medical Director: Luis Campillo, MD

    Last reviewed: May 20, 2026

    This page is for educational purposes only and does not constitute medical advice. All treatments require an individualized medical evaluation. DMHealth provides services via telehealth to Florida residents under the medical supervision of Luis Campillo, MD, in accordance with Florida Statutes § 458.347 governing physician assistant practice. Some statements have not been evaluated by the U.S. Food and Drug Administration; products mentioned are not intended to diagnose, treat, cure, or prevent any disease.